Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-06-28
2005-06-28
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S182000
Reexamination Certificate
active
06911444
ABSTRACT:
The present invention relates to IL-5 inhibiting 6-azauracil derivatives useful for treating eosinophil-dependent inflammatory diseases, to processes and intermediates for their preparation as well as to pharmaceutical compositions comprising the said derivatives. It further relates to the use of such derivatives as a medicine, and to processes for marking a receptor or imaging an organ using the said derivatives.
REFERENCES:
patent: 4631278 (1986-12-01), Boeckx et al.
patent: 2002/0010177 (2002-01-01), Freyne et al.
patent: 2002/0042416 (2002-04-01), Freyne et al.
patent: 0170316 (1990-05-01), None
patent: 0232932 (1991-01-01), None
patent: 0987265 (2000-03-01), None
patent: 2 532 313 (1984-02-01), None
patent: WO 99/02504 (1999-01-01), None
patent: WO 99/02505 (1999-01-01), None
Wang-Lin, Y., et al., “Synthesis of 1,4-bis(1,3,4-oxadiazol-2-yl)-2,5-dialkoxybenzene-oligothiophene copolymers with different emissive colors: synthetically tuning the photoluminescence of conjugated polymers.”Chemical Comm.1957, pp. 1957-1958.
Buzas, A., et al., CAPLUS Accession No. 1961:131401, Chemical Abstract, 1961, vol. 55, Abstract # 131,401.
Peet, N.P., et al., “Synthesis of a Novel indolobenzodiazepine.”J. Heterocyclic Chem., 1983, pp. 1355-1357, vol. 20.
Carr, M. W. et al., “Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant.”.Proc. Natl. Acad. Sci.1994, 91, 3652-3656.
Baggiolini, M., et al., CC chemokines in allergic inflammation,Immunology Today, 1994, 15(3), 127-133.
PCT International Search Report PCT/EP00/07358 dated Jan. 25, 2001, which relates to U.S. Appl. 10/075,876.
Published Application for U.S. Patent 2002/0010177 (A1), which relates in family to EP 0987265, and a MicroPatent® Family Lookup.
Office Action received in U.S. Appl. No. 10/049,038 to which U.S. Appl. No. 10/075,876 claims priority as a continuation-in-part thereof.
Published Application for U.S. Patent 20020042416 (A1), and a MicroPatent® Family Lookup.
Coesemans Erwin
Deroose Frederik Dirk
Fortin Jérôme Michel Claude
Freyne Eddy Jean Edgard
Lacrampe Jean Fernand Armand
Balasubramanian Venkataraman
Janssen Pharmaceutics N.V.
Kriegsman Alana G.
Lopez Gabriel
Raymond Richard L.
LandOfFree
Non-steroidal IL-5 inhibitors, processes and intermediates... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-steroidal IL-5 inhibitors, processes and intermediates..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-steroidal IL-5 inhibitors, processes and intermediates... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3483947